Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Imiquimod + Metformin + Recombinant human papillomavirus 9-valent vaccine |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Imiquimod | Aldara | Imiquimod acetate | ||
| Metformin | Glucophage | Apo-Metformin | mTOR Inhibitor 51 | Glucophage (metformin) inhibits part of the mitochondrial respiratory chain and may exert antineoplastic effects through inhibition of mTOR and is FDA approved for type 2 diabetes (FDA.gov). |
| Recombinant human papillomavirus 9-valent vaccine | Gardasil 9 | Gardasil-9|Gardasil9|Nonavalent HPV VLP Vaccine|9vHPV | Gardasil 9 (recombinant human papillomavirus 9-valent vaccine) is a recombinant human papillomavirus (HPV) virus-like particle vaccine against 9 oncogenic HPV types, which potentially enhances antitumor immune response (PMID: 25693011, PMID: 26090572, PMID: 38445009). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06686043 | Phase II | Imiquimod + Metformin + Recombinant human papillomavirus 9-valent vaccine | HPV Vaccine, Imiquimod, and Metformin Combination Trial (HPV-VIM) | Recruiting | USA | 0 |